期刊文献+

α-Galcer干预自身免疫疾病研究新进展 被引量:1

原文传递
导出
摘要 自身免疫疾病是机体针对自身抗原发生免疫反应而导致的多系统疾病,发病原因可能与调节性T细胞有关。尽管人们对于调节性T细胞的免疫调节机制有所了解,但是大多数调节性T细胞亚型的抗原特异性仍不清楚,因此很难利用这些细胞的免疫调节活性达到治疗目的。
作者 郭丽萍 王元
出处 《中华风湿病学杂志》 CAS CSCD 2006年第12期757-759,共3页 Chinese Journal of Rheumatology
基金 上海市浦东新区科技专项资金资助(PKJ2002-61)
  • 相关文献

参考文献22

  • 1Celia R,Huib O.Immunotherapeutic potential for ceramide-based activators of iNKT cells.Elsevier Rev,2005,26:252-257.
  • 2Kobayashi E,Motoki K,Uchida T,et al.KRN7000,a novel immunomodulator,and its antitumor activities.Oncol Res,1995,7:529-534.
  • 3Benlagha K,Weiss A,Beavis A,et al.In vivo identification of glycolipid antigen-specific T cells using fluorescent CDld tetramers.J Exp Med,2000,191:895-903.
  • 4Naidenko OV,Gapin L,Nakayama T,et al.Tracking the response of natural killer T cells to a glycolipid antigen using CDld tetramers.J Exp Med,2000,92:41-54.
  • 5Hayakawa YD,Godfrey DI,Mark JS.Alpha-galactosylceramide:potential immunomodulatory activity and future application.Curr Med Chem,2004,11:241-252
  • 6Wilson SB,Delovitch TL.Janus-like role of regulatory iNKTcells in autoimmune disease and tumour immunity.Nat Rev Immunol,2003,3:211-222.
  • 7Taniguchi M,Harada M,Kojo S,et al.The regulatory role of Valphal4 NKT cells in innate and acquired immune response.Annu Rev Immunol,2003,21:483-513.
  • 8Van Kaer L.Natural killer T cells as targets for immunotherapy of autoimmune disease.Immunol Cell Biol,2004,82:315-322.
  • 9李春明,王元.CD1与自身免疫性疾病的研究进展[J].中华风湿病学杂志,2004,8(9):554-557. 被引量:2
  • 10Joyce S,Woods AS,Yewdell JW,et al.Natural ligand of mouse CDldl:cellular glycosylphosphatidylinositol.Science,1998,279:41-44.

二级参考文献34

  • 1Calabi R, Jarvis M, Martin L, et al. Two classes of CDI genes.Eur J Immunol, 1989, 19: 285-292.
  • 2Riese RJ, Shi GP, Villadangos J, et al. Regulation of CD1 function and NK1.1(+) T cell selection and maturation by cathepsin S.Immunity, 2001, 15: 909-919.
  • 3Honey K, Benlagha K, Beers C, et al. Thymocyte expression of cathepsin L is essential for NKT cell development. Nat Immunol,2002, 3: 1069-1074.
  • 4Zeng D, Lee MK, Tung J, et al. Cutting edge: a role for CD1 in the pathogensis of lupus in NZB/NZW mice. Immunol, 2000, 164:5000-5004.
  • 5Sieling PA, Porcelli SA, Duong BT, et al. Human double-negative T cells in systemic lupus erythematosus provide help for IgG and are restricted by CDlc. J Immunol, 2000, 165: 5338-5344.
  • 6Yang JQ, Singh AK, Wilson MT, et al. Immunoregulatory role of CDd in the hydrocarbon oil-induced model of lupus nephritis. J Immumol, 2003, 171: 2142-2153.
  • 7Cauli A, Pitzalis C, Yanni G, et al. CD1 expression in psoriatic and rheumatoid arthritis. Rheumatology, 2000, 39: 666-673.
  • 8Sugita M, Grant EP, van Donselaar E, et al. Separat pathways for antigen presentation by CDe molecules. Immunity, 1999, 11:743-752.
  • 9Moody DB, Briken V, Cheng TY, et al. Lipid length controls antigen entry into endosomal and nonendosomal pathways for CDlb presentation. Nat Immunol, 2002, 3: 435-442.
  • 10Ernst WA, Maher J, Cho S, et al. Molecular interaction of CDlb with lipoglycan antigens. Immunity, 1998, 8: 331-340.

共引文献2

同被引文献7

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部